Physician profile
Mun Aw
NPI 1396264925
$1,559.85
in general payments reported to CMS, 2019-2025
18 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.68 · 2023: $655 · 2024: $781 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,547.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $309.15 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $303.16 | 2023-2024 | Lifevest |
| Edwards Lifesciences Corporation | $185.07 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Atricure, INC. | $162.41 | 2024 | |
| Medtronic, INC. | $128.13 | 2023 | Micra, Endurant Iis |
| Merck Sharp & Dohme LLC | $62.24 | 2024 | Verquvo |
| Amgen INC. | $47.08 | 2023-2024 | Repatha |
| Pfizer INC. | $46.63 | 2023 | |
| Janssen Pharmaceuticals, INC | $41.13 | 2023 | Xarelto |
| Kiniksa Pharmaceuticals, LTD. | $38.31 | 2023 | Arcalyst |
| Biosense Webster, INC. | $37.86 | 2023 | Carto 3 |
| Kiniksa Pharmaceuticals International, Plc | $37.56 | 2024 | Arcalyst |
| Tactile Systems Technology INC | $36.84 | 2024 | Flexitouch Plus, Entre Plus |
| Actelion Pharmaceuticals US, INC. | $35.70 | 2025 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.66 | 2024 | Jardiance |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $26.52 | 2025 | Cardiomems |
| Lexicon Pharmaceuticals, INC. | $14.72 | 2023 | Inpefa |
| E.R. Squibb & Sons, L.L.C. | $12.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mun Aw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.